Operating Income (Loss) in USD of Vir Biotechnology, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vir Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to Q3 2025.
  • Vir Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$173M, a 25% increase year-over-year.
  • Vir Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$549M, a 9.93% increase year-over-year.
  • Vir Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$587M, a 14.2% increase from 2023.
  • Vir Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$684M, a 182% decline from 2022.
  • Vir Biotechnology, Inc. annual Operating Income (Loss) for 2022 was $833M, a 98% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Vir Biotechnology, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$549M -$173M +$57.9M +25% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 -$606M -$118M +$40.2M +25.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 -$647M -$140M -$59.5M -74.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$587M -$117M +$21.9M +15.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$609M -$231M -$44.6M -23.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$564M -$159M +$56.6M +26.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$621M -$80.1M +$63.3M +44.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$684M -$139M +$11.5M +7.63% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$696M -$187M -$382M -196% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$314M -$215M +$10M +4.46% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$324M -$143M -$1.16B -114% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $833M -$151M -$722M -126% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $1.56B $195M +$248M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.31B -$225M -$286M -469% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $1.59B $1.01B +$1.17B Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $421M $572M +$680M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$259M -$53.4M +$34.2M +39.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$294M $61M +$90.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$384M -$159M -$86.7M -121% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$297M -$108M -$44.6M -70% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$252M -$87.6M -$39.9M -83.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$212M -$29.1M +$6.72M +18.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$219M -$71.9M -$41.1M -134% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$178M -$63.8M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$47.7M -$13.3M -38.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$35.8M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$30.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 -$34.3M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19

Vir Biotechnology, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$587M +$97.1M +14.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$684M -$1.52B -182% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $833M +$412M +98% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $421M +$718M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$297M -$119M -66.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$178M -$59.3M -50% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$119M -$37.2M -45.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$81.5M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.